We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

This study has been terminated.
(no value in finding efficacy)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01174199
First Posted: August 3, 2010
Last Update Posted: September 13, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Merck Sharp & Dohme Corp.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Roswell Park Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2016
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)